Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

2.

Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.

Cochrane Database Syst Rev. 2010 May 12;(5):CD005535. doi: 10.1002/14651858.CD005535.pub2. Review.

3.

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

Salpeter SR, Ormiston TM, Salpeter EE.

Chest. 2004 Jun;125(6):2309-21.

PMID:
15189956
4.

Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

Ducharme FM, Ni Chroinin M, Greenstone I, Lasserson TJ.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD005533. doi: 10.1002/14651858.CD005533.pub2. Review.

5.

A systematic review of long-acting β2-agonists versus higher doses of inhaled corticosteroids in asthma.

Castro-Rodriguez JA, Rodrigo GJ.

Pediatrics. 2012 Sep;130(3):e650-7. doi: 10.1542/peds.2012-0162. Epub 2012 Aug 27. Review.

6.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

7.

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2011 May 11;(5):CD003137. doi: 10.1002/14651858.CD003137.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003137.

PMID:
21563136
9.
10.

Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.

Hirst C, Calingaert B, Stanford R, Castellsague J.

J Asthma. 2010 May;47(4):439-46. doi: 10.3109/02770901003605340.

PMID:
20528600
11.

Continuous versus intermittent beta-agonists in the treatment of acute asthma.

Camargo CA Jr, Spooner CH, Rowe BH.

Cochrane Database Syst Rev. 2003;(4):CD001115. Review.

PMID:
14583926
12.

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE.

Ann Intern Med. 2006 Jun 20;144(12):904-12. Epub 2006 Jun 5.

PMID:
16754916
13.

Long-acting β-agonists in asthma management: what is the current status?

Mysore S, Ruffin RE.

Drugs. 2011 Nov 12;71(16):2091-7. doi: 10.2165/11596260-000000000-00000.

PMID:
22035511
14.

CpG oligodeoxynucleotides as TLR9 agonists: therapeutic application in allergy and asthma.

Gupta GK, Agrawal DK.

BioDrugs. 2010 Aug 1;24(4):225-35. doi: 10.2165/11536140-000000000-00000. Review.

PMID:
20623989
15.

Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.

Ni Chroinin M, Greenstone I, Lasserson TJ, Ducharme FM.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005307. doi: 10.1002/14651858.CD005307.pub2. Review.

16.

beta-Adrenoceptor inverse agonists in asthma.

Dickey BF, Walker JK, Hanania NA, Bond RA.

Curr Opin Pharmacol. 2010 Jun;10(3):254-9. doi: 10.1016/j.coph.2010.03.002. Review.

17.

Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.

Ni Chroinin M, Lasserson TJ, Greenstone I, Ducharme FM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007949. doi: 10.1002/14651858.CD007949. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD007949.

18.

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).

Keith PK, Koch C, Djandji M, Bouchard J, Psaradellis E, Sampalis JS, Schellenberg RR, McIvor RA.

Can Respir J. 2009 May-Jun;16 Suppl A:17A-31A. English, French.

19.

Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children.

Plotnick LH, Ducharme FM.

Cochrane Database Syst Rev. 2000;(4):CD000060. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD000060.

PMID:
11034671
20.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
Items per page

Supplemental Content

Write to the Help Desk